These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13364127)

  • 1. The carcinogenicity of beta-propiolactone for mouseskin.
    GLENDENNING OM; ROE FJ
    Br J Cancer; 1956 Jun; 10(2):357-62. PubMed ID: 13364127
    [No Abstract]   [Full Text] [Related]  

  • 2. Further studies on incomplete carcinogenesis: triethylene melamine (T.E.M.), 1,2-benzanthracene and beta-propiolactone, as initiators of skin tumour formation in the mouse.
    ROE FJ; SALAMAN MH
    Br J Cancer; 1955 Mar; 9(1):177-203. PubMed ID: 14378502
    [No Abstract]   [Full Text] [Related]  

  • 3. The binding of beta-propiolactone and some related alkylating agents to DNA, RNA, and protein of mouse skin; relation between tumor-initiating power of alkylating agents and their binding to DNA.
    Colburn NH; Boutwell RK
    Cancer Res; 1968 Apr; 28(4):653-60. PubMed ID: 5649056
    [No Abstract]   [Full Text] [Related]  

  • 4. The carcinogenicity of beta-propiolactone and 4-nitroquinoline N-oxide for the skin of the guinea-pig.
    Parish DJ; Searle CE
    Br J Cancer; 1966 Mar; 20(1):200-5. PubMed ID: 5936681
    [No Abstract]   [Full Text] [Related]  

  • 5. The carcinogenicity of beta-propiolactone and 4-nitroquinoline N-oxide for the skin of the golden hamster.
    Parish DJ; Searle CE
    Br J Cancer; 1966 Mar; 20(1):206-9. PubMed ID: 5936682
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of beta-propiolactone on the metabolism of Candida albicans.
    GALE GR
    J Infect Dis; 1955; 96(3):250-8. PubMed ID: 14392370
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of beta-propiolactone on bacterial spores.
    CURRAN HR; EVANS FR
    J Infect Dis; 1956; 99(3):212-8. PubMed ID: 13376916
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inactivation and antigenicity of poliomyelitis virus type 2 (MEF-1 strain) treated with beta-propiolactone].
    D'ALESSANDRO G; ODDO FG; INSERILLO G
    Riv Ist Sieroter Ital; 1956; 31(1):65-8. PubMed ID: 13337026
    [No Abstract]   [Full Text] [Related]  

  • 9. The inhibition of respiration of certain dermatophytes by beta propiolactone.
    GALE GR
    J Invest Dermatol; 1954 Jan; 22(1):1-3. PubMed ID: 13118247
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigenicity of beta-propiolactone-inactivated virus vaccines.
    LOGRIPPO GA; HARTMAN FW
    J Immunol; 1955 Aug; 75(2):123-8. PubMed ID: 13242811
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antigenic and vaccinating power of Newcastle virus inactivated by beta-propiolactone].
    LEPINE P; ATANASIU P
    Ann Inst Pasteur (Paris); 1956 Jul; 91(1):100-2. PubMed ID: 13340335
    [No Abstract]   [Full Text] [Related]  

  • 12. The activity of human regains exposed to the disinfectant, beta-propiolactone.
    FLICK JA; FEINBERG RJ
    J Allergy; 1955 May; 26(3):262-7. PubMed ID: 14366906
    [No Abstract]   [Full Text] [Related]  

  • 13. Serological response in chickens to beta-propiolactone treated Newcastle disease virus.
    MACK WN; CHOTISEN A
    Proc Soc Exp Biol Med; 1956 Feb; 91(2):288-90. PubMed ID: 13297779
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined use of ultraviolet irradiation and beta propiolactone sterilization of sera infected with a virus.
    SMOLENS J; STOKES J
    Proc Soc Exp Biol Med; 1954 Jul; 86(3):538-9. PubMed ID: 13194713
    [No Abstract]   [Full Text] [Related]  

  • 15. Skin irritation and skin tumor production by beta propiolactone (BPL).
    PALMES ED; ORRIS L; NELSON N
    Am Ind Hyg Assoc J; 1962; 23():257-64. PubMed ID: 14483427
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of beta-propiolactone and neighboring derivatives on the in vitro synthesis of DNA or RNA].
    Moreau J; Daudel P
    Bull Cancer; 1972; 59(3):331-8. PubMed ID: 4667742
    [No Abstract]   [Full Text] [Related]  

  • 17. Experiments on the carcinogenicity and reactivity of beta-propiolactone.
    SEARLE CE
    Br J Cancer; 1961 Dec; 15(4):804-11. PubMed ID: 13910215
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the clastogenic and carcinogenic effects of intravenous beta-propiolactone and benzo(a)pyrene in rats.
    Rees ED; Shuck AE; Lowry JQ; Smith TM; Lipscomb H
    J Environ Pathol Toxicol; 1979; 2(6):1475-85. PubMed ID: 528852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by actinomycin D of DNA and RNA synthesis and of skin carcinogenesis initiated by 7,12-dimethylbenz[a]anthracene or beta-propiolactone.
    Hennings H; Smith HC; Colburn NH; Boutwell RK
    Cancer Res; 1968 Mar; 28(3):543-52. PubMed ID: 5640870
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of hydroxyurea on DNA and RNA synthesis in mouse skin, liver, and thymus and on skin tumorigenesis initiated by beta-propiolactone.
    Smith HC; Boutwell RK; Potter VR
    Cancer Res; 1968 Nov; 28(11):2217-27. PubMed ID: 5723966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.